Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL1478381 | 0.98 | L3MBTL1 (0.32) | L3MBTL1EPHX2 | |
| SCHEMBL3285292 | 0.86 | EPHX2 (0.38) | L3MBTL1EPHX2 | |
| SCHEMBL3282752 | 0.86 | EPHX2 (0.38) | L3MBTL1EPHX2 | |
| SCHEMBL3282039 | 0.74 | CYP2C9 (0.35) | EPHX2 | |
| SCHEMBL2056515 | 0.74 | — | — | |
| SCHEMBL2000495 | 0.67 | CYP2C9 (0.33) | EPHX2 | |
| Butane SCHEMBL1524676 | 0.64 | L3MBTL1 (0.38) | L3MBTL1EPHX2 | |
| SCHEMBL6346244 | 0.64 | CYP2C9 (0.36) | L3MBTL1EPHX2 | |
| Adamantane SCHEMBL1071737 | 0.63 | L3MBTL1 (0.37) | L3MBTL1EPHX2 | |
| SCHEMBL18633026 | 0.63 | CNR2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024199209-A1 | METHOD FOR SYNTHESIZING KEY INTERMEDIATE OF SELECTIVE THR ΒETA AGONIST | 西藏海思科制药有限公司 | 2024-10-03 | — | — | WO | claimed |
| WO-2024199209-A1 | METHOD FOR SYNTHESIZING KEY INTERMEDIATE OF SELECTIVE THR ΒETA AGONIST | 西藏海思科制药有限公司 | 2024-10-03 | — | — | WO | disclosed |
| EP-3794049-B1 | METHOD FOR PRODUCING A POLYISOCYANATE POLYMER AND A POLYISOCYANURATE PLASTIC | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-06-08 | — | — | EP | disclosed |
| US-11319402-B2 | Method for producing a polyisocyanate polymer and a polyisocyanurate plastic | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2022-05-03 | — | — | US | disclosed |
| US-20220127407-A1 | POLYISOCYANURATE MATERIALS AS ELECTRICAL POTTING COMPOUNDS | COVESTRO DEUTSCHLAND AG (DE) | 2022-04-28 | — | — | US | disclosed |
| EP-3931185-A1 | POLYISOCYANURATE MATERIALS AS ELECTRICAL POTTING COMPOUNDS | Covestro Intellectual Property GmbH & Co. KG (DE) | 2022-01-05 | — | — | EP | disclosed |
| US-20210246255-A1 | METHOD FOR PRODUCING A POLYISOCYANATE POLYMER AND A POLYISOCYANURATE PLASTIC | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2021-08-12 | — | — | US | disclosed |
| US-20210214487-A1 | METHOD FOR PREPARING COMPOSITE MATERIALS MADE OF POLYETHYLENE FIBERS HAVING AN ULTRA-HIGH MOLECULAR WEIGHT AND CROSS-LINKED POLYISOCYANATES | COVESTRO DEUTSCHLAND AG (DE) | 2021-07-15 | — | — | US | disclosed |
| EP-3794049-A1 | METHOD FOR PRODUCING A POLYISOCYANATE POLYMER AND A POLYISOCYANURATE PLASTIC | Covestro Intellectual Property GmbH & Co. KG (DE) | 2021-03-24 | — | — | EP | disclosed |
| EP-3794050-A1 | METHOD FOR PREPARING COMPOSITE MATERIALS MADE OF POLYETHYLENE FIBERS HAVING AN ULTRA-HIGH MOLECULAR WEIGHT AND CROSS-LINKED POLYISOCYANATES | Covestro Intellectual Property GmbH & Co. KG (DE) | 2021-03-24 | — | — | EP | disclosed |
| US-20160126468-A1 | INDENOINDOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO., LTD. (JP) | 2016-05-05 | — | — | US | disclosed |
| EP-3006426-A1 | INDENOINDOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2016-04-13 | — | — | EP | disclosed |
| CN-103265501-B | Method for producing N-phenyl-N'-phenylsulfonylpiperazine derivative | SHIONOGI & CO | 2015-06-03 | — | — | CN | disclosed |
| US-20150057447-A1 | METHOD OF PRODUCING N-PHENYL-N'-PHENYLSULFONYL PIPERAZINE DERIVATIVE AND INTERMEDIATE THEREOF | SHIONOGI & CO., LTD. (JP) | 2015-02-26 | — | — | US | disclosed |
| EP-2832729-A1 | N-PHENYL-N'-PHENYLSULFONYLPIPERAZINE DERIVATIVE AND METHOD FOR PRODUCING INTERMEDIATE FOR SAME | Shionogi & Co., Ltd. (JP) | 2015-02-04 | — | — | EP | disclosed |
| CN-103265501-A | Method for producing N-phenyl-N'-phenylsulfonylpiperazine derivative | SHIONOGI & CO | 2013-08-28 | — | — | CN | disclosed |
| US-20110237836-A1 | Method for Producing Alkylnitrobenzenes and Alkylanilines, Unbranched in the 1'-Position, from Nitrotoluenes | BAYER CROPSCIENCE AG (DE) | 2011-09-29 | — | — | US | disclosed |
| US-7709680-B2 | Preparation of polyisocyanates containing uretdione groups using phosphine catalysts | BAYER MATERIALSCIENCE AG (DE) | 2010-05-04 | — | — | US | disclosed |
| CN-101679267-A | Process for producing N-phenyl-N' -benzenesulfonylpiperazine derivative | SHIONOGI & CO | 2010-03-24 | — | — | CN | disclosed |
| US-20080262262-A1 | Preparation of polyisocyanates containing uretdione groups using phosphine catalysts | BAYER MATERIALSCIENCE AG | 2008-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160126468-A1 | INDENOINDOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | IDO2, SLCO2B1, IDO1 | L3MBTL1 2737/4885EPHX2 350/4885 |
| US-20080262262-A1 | Preparation of polyisocyanates containing uretdione groups using phosphine catalysts | PPIP5K2, IPMK, INPP5B | L3MBTL1 4770/4885EPHX2 2018/4885 |
| US-20110237836-A1 | Method for Producing Alkylnitrobenzenes and Alkylanilines, Unbranched in the 1'-Position, from Nitrotoluenes | CYP1B1, CYP1A1, CYP1A2 | L3MBTL1 1544/4885EPHX2 2233/4885 |
| US-20150057447-A1 | METHOD OF PRODUCING N-PHENYL-N'-PHENYLSULFONYL PIPERAZINE DERIVATIVE AND INTERMEDIATE THEREOF | REN, JAK2, XDH | L3MBTL1 4664/4885EPHX2 2747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.